Last reviewed · How we verify
Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis
This study evaluates the effectiveness of Dupilumab in food allergic patients with moderate to severe Atopic Dermatitis (AD). Included patients participated in the BioDay Registry.
Details
| Lead sponsor | UMC Utrecht |
|---|---|
| Status | TERMINATED |
| Enrolment | 3 |
| Start date | Wed May 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Jul 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Food Allergy
Countries
Netherlands